Scarica l'app Stockscreener
20.05
3.79%
-0.79
Pre-mercato:
20.05
Evommune Inc Borsa (EVMN) Ultime notizie
Evommune Inc. (EVMN) Declines 4.16% as Stock Tests Key Support at $18.84Double EMA - newsline.com
Evommune Inc. (EVMN) Slips 4.16% as Biotech Sentiment SoftensMomentum Stock Picks - newsline.com
This Biotech Stock Nearly Doubled In Value Today Morning – What’s Driving Investor Optimism? - Stocktwits
EVMN SEC FilingsEVOMMUNE INC 10-K, 10-Q, 8-K Forms - Stock Titan
Evommune director Cohen sells $123,093 in stock By Investing.com - Investing.com India
Insider Sell: Luis Pena Sells Shares of Evommune Inc (EVMN) - GuruFocus
Evommune CSO Patel sells $379k, acquires $51k in stock - Investing.com UK
Evommune president & CEO Luis C. Pena sells $381,736 in stock - Investing.com Nigeria
Evommune president & CEO Luis C. Pena sells $381,736 in stock By Investing.com - Investing.com South Africa
Evommune director Cohen sells $123,093 in stock - Investing.com
Evommune CSO Patel sells $379k, acquires $51k in stock By Investing.com - Investing.com Australia
Evommune (EVMN) grants director 15,673 stock options at $19.82 - Stock Titan
Evommune (EVMN) CEO Luis C. Pena sells 16,787 shares under 10b5-1 plan - Stock Titan
Evommune (EVMN) director sells 6,056 shares and receives option grant - Stock Titan
Broker files proposed sale of EVMN (NYSE: EVMN) — 9,258 shares listed - Stock Titan
Evommune (EVMN) elects directors and ratifies BDO as auditor - Stock Titan
Evommune (EVMN) investors back board nominees and ratify BDO USA as 2026 auditor - Stock Titan
EVMN: Directors and auditor were approved, with no shareholder questions and quorum established - TradingView
Evommune CFO Kyle Carver sells $415,117 of EVMN stock By Investing.com - Investing.com UK
Evommune chief business & legal officer sells $324,711 in stock By Investing.com - Investing.com Australia
Evommune CFO Kyle Carver sells $415,117 of EVMN stock - Investing.com
Evommune chief business & legal officer sells $324,711 in stock - Investing.com
Evommune (EVMN) officer exercises options and sells 14,223 shares under 10b5-1 plan - Stock Titan
Evommune (EVMN) CFO sells 18,175 shares under 10b5-1 plan - Stock Titan
Morgan Stanley Smith Barney (EVMN) files Form 144 listing 24,225 shares - Stock Titan
15,000-Share Rule 144 Notice for EVMN (EVMN) by Morgan Stanley - Stock Titan
Number of shareholders of Evommune, Inc. – NYSE:EVMN - TradingView
[144] Evommune, Inc. SEC Filing - Stock Titan
EVMN (NYSE: EVMN) broker files to sell 22,500 shares on 05/28/2026 - Stock Titan
Evommune Inc. (EVMN) Slides 1.46% Amid Cautious Sector Tone; Support at $21.85 in FocusDonchian Channel - newsline.com
H.C. Wainwright Maintains Evommune(EVMN.US) With Buy Rating, Maintains Target Price $50 - Moomoo
Evommune Inc. (EVMN) Q1 2026 Earnings: EPS Beats Estimates as Pre-Revenue Biotech Focuses on Pipeline ProgressProduct Revenue Analysis - The Legal Advocate
H.C. Wainwright reiterates Evommune stock rating on trial progress By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Evommune stock rating on trial progress - Investing.com
Number of shareholders of Evommune, Inc. – BX:EVMN - TradingView
Evommune (EVMN) Insider Trading Activity 2026 - MarketBeat
Evommune (EVMN) Institutional Ownership 2026 - MarketBeat
Oppenheimer Maintains Evommune(EVMN.US) With Buy Rating, Maintains Target Price $50 - Moomoo
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):